Prostate Cancer

Higher levels of a certain type of immune cell may explain why immunotherapy for prostate cancer is more effective in Black men than in white men, researchers say. The finding could lead to immunotherapy-based precision treatment for localized aggressive and advanced prostate cancer in all races. For the study, the researchers analyzed 1,300 prostate tumor...

Cancer prevalence worldwide is rapidly increasing, with cases expected to increase from 18.1 to 24.6 million by 2030. Differences in carcinogen exposure, diagnostic center access, and treatment affordability have increased gaps in cancer outcomes and death rates worldwide. In this review, the authors highlight factors contributing to prostate cancer care disparities among African Americans and...

Pooled relative risk of 0.988 for each increment of one cup of coffee per day revealed in meta-analysis of cohort studies Increased coffee consumption is associated with a reduced risk for prostate cancer, according to a review and meta-analysis published online Jan. 11 in BMJ Open. Xiaonan Chen, from Shengjing Hospital of China Medical University, and...

The risk of getting prostate cancer is 75% higher for Black men than it is for white men, and it is more than twice as deadly. Now, research is helping to bring genetic risks for people of various racial and ethnic groups into focus. In doing so, dozens more risk factors that could better help...

Prostate Cancer Clinical Trials Lack Racial Diversity  Investigators report that although 22% of prostate cancer diagnoses take place in non-Hispanic Black men, more than 96% of participants in prostate cancer clinical trials are non-Hispanic white men. That was the conclusion published in Cancer Epidemiology, Biomarkers, and Prevention. Worse, enrollment of African American men in prostate...

According to a study published in The Journal of Urology, Black men with prostate cancer suffer worse decisional regret than non Black men. The study, conducted by the Cleveland Clinic and led by Dr. Molly E. DeWitt Foy, took a closer look at sources of regret with a focus on racial disparities among 1,113 patients...

A multiple cohort study sponsored by the National Cancer Institute and Veterans Affairs Health System was conducted to determine if black men suffer at a higher prostate cancer mortality rate than non-Hispanic white men. Numerous trials have resulted in conflicting findings pertaining to the association between prostate mortality rate and association with other-cause mortality rates...

By Dr. Mark Abdelmalek and Lucien bruggeman At the onset of the novel coronavirus, American healthcare providers sought to limit non-essential in-person visits, opting instead to put off routine examinations – including annual cancer screenings – as part of an effort to curb risky face-to-face interactions. This precautionary approach was endorsed by the American Cancer Society,...

Transcriptional profiling identifies a gene program active in metastatic prostate cancers that failed to respond to enzalutamide treatment. Over the last decade, enzalutamide and similar drugs have led to significant tumor control and increased survival time for men who have metastatic prostate cancer that continues to grow despite treatments to reduce male hormone levels. About...